Selected article for: "acute inflammation and chronic infection"
Author: Rahban, Mahdie; Habibi-Rezaei, Mehran; Mazaheri, Mansoureh; Saso, Luciano; Moosavi-Movahedi, Ali A.
Title: Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications
  • Cord-id: oit7hofq
  • Document date: 2020_12_4
    • ID: oit7hofq
    Snippet: Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential transcription factor that maintains the cell’s redox balance state and reduces inflammation in different adverse stresses. Under the oxidative stress, Nrf2 is separated from Kelch-like ECH-associated protein 1 (Keap1), which is a key sensor of oxidative stress, translocated to the nucleus, interacts with the antioxidant response element (ARE) in the target gene, and then activates the transcriptional pathway to ameliorate the c
    Document: Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential transcription factor that maintains the cell’s redox balance state and reduces inflammation in different adverse stresses. Under the oxidative stress, Nrf2 is separated from Kelch-like ECH-associated protein 1 (Keap1), which is a key sensor of oxidative stress, translocated to the nucleus, interacts with the antioxidant response element (ARE) in the target gene, and then activates the transcriptional pathway to ameliorate the cellular redox condition. Curcumin is a yellow polyphenolic curcuminoid from Curcuma longa (turmeric) that has revealed a broad spectrum of bioactivities, including antioxidant, anti-inflammatory, anti-tumor, and anti-viral activities. Curcumin significantly increases the nuclear expression levels and promotes the biological effects of Nrf2 via the interaction with Cys151 in Keap1, which makes it a marvelous therapeutic candidate against a broad range of oxidative stress-related diseases, including type 2 diabetes (T2D), neurodegenerative diseases (NDs), cardiovascular diseases (CVDs), cancers, viral infections, and more recently SARS-CoV-2. Currently, the multifactorial property of the diseases and lack of adequate medical treatment, especially in viral diseases, result in developing new strategies to finding potential drugs. Curcumin potentially opens up new views as possible Nrf2 activator. However, its low bioavailability that is due to low solubility and low stability in the physiological conditions is a significant challenge in the field of its efficient and effective utilization in medicinal purposes. In this review, we summarized recent studies on the potential effect of curcumin to activate Nrf2 as the design of potential drugs for a viral infection like SARS-Cov2 and acute and chronic inflammation diseases in order to improve the cells’ protection.

    Search related documents:
    Co phrase search for related documents
    • activation strategy and acute ards respiratory distress syndrome: 1, 2
    • activation strategy and acute lung injury: 1, 2
    • activation strategy and acute respiratory distress syndrome: 1, 2
    • active compound and acute ards respiratory distress syndrome: 1, 2
    • active compound and acute liver injury: 1
    • active compound and acute lung injury: 1, 2, 3
    • active compound and acute respiratory distress syndrome: 1, 2
    • active compound and liver injury: 1, 2
    • activity mechanism and acute ards respiratory distress syndrome: 1
    • activity mechanism and acute lung injury: 1, 2, 3, 4, 5
    • activity mechanism and acute respiratory distress syndrome: 1, 2, 3, 4
    • activity mechanism and liver injury: 1
    • acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and liver organ: 1, 2, 3, 4
    • acute kidney injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute kidney injury and liver organ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute liver injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute liver injury and liver organ: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute lung injury and liver organ: 1, 2, 3, 4